Tuberculosis and HIV coinfection: Current state of knowledge and research priorities

Journal of Infectious Diseases

Volumn 196, Issue SUPPL. 1, 2007, Pages

  Friedland, Gerald ^a   Churchyard, Gavin J ^d,e,f   Nardell, Edward ^b,c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c PARTNERS IN HEALTH   (United States)

^d AURUM INSTITUTE   (South Africa)

^e UNIVERSITY OF KWAZULU NATAL   (South Africa)

^f LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CONFERENCE PAPER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KNOWLEDGE BASE; PRIORITY JOURNAL; RESEARCH PRIORITY; SUPERINFECTION; TUBERCULOSIS;

HIV INFECTIONS; HUMANS; TUBERCULOSIS; WORLD HEALTH;

EID: 34547629992     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/518667     Document Type: Conference Paper

References (17)

1. World Health Organization (WHO). Global tuberculosis control surveillance, planning, financing: WHO report 2006. WHO/HTM/TB/2006.362. Geneva: WHO, 2006.
2. Joint United Nations Programme on HIV/AIDS (UNAIDS). Report on the global AIDS epidemic. UNAIDS/05.19E. 2006.
3. Corbett EL, Marston B, Churchyard GJ, De Cock KM. Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment. Lancet 2006; 367:926-37.
4. Gandhi NR, Moll A, Sturm AW, et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 2006; 368:1575-80.
5. World Health Organization (WHO). Interim policy on collaborative TB/HIV activities. In: Stop TB Department and HIV/AIDS Department, WHO, eds. HIV/AIDS. Geneva: WHO, 2004.
6. Nunn P, Reid A, De Cock KM. Tuberculosis and HIV infection: the global setting. J Infect Dis 2007; 196(Suppl 1):S5-14 (in this supplement).
7. Perkins MD, Cunningham J. Facing the crisis: improving the diagnosis of tuberculosis in the HIV era. J Infect Dis 2007; 196(Suppl 1): S15-27 (in this supplement).
8. Spigelman MK. New tuberculosis therapeutics: a growing pipeline. J Infect Dis 2007; 196(Suppl 1):S28-34 (in this supplement).
9. Onyebujoh PC, Ribeiro I, Whalen CC. Treatment options for HIV-associated tuberculosis. J Infect Dis 2007; 196(Suppl 1):S35-45 (in this supplement).
10. Blanc F-X, Havlir DV, Onyebujoh PC, Thim S, Goldfeld AE, Delfraissy J-F. Treatment strategies for HIV-infected patients with tuberculosis: ongoing and planned clinical trials. J Infect Dis 2007; 196(Suppl 1):S46-51 (in this supplement).
11. McIlleron H, Meintjes G, Burman WJ, Maartens G. Complications of antiretroviral therapy in patients with tuberculosis: drug interactions, toxicity, and immune reconstitution inflammatory syndrome. J Infect Dis 2007; 196(Suppl 1):S63-75 (in this supplement).
12. Churchyard GJ, Scano F, Grant AD, Chaisson RE. Tuberculosis preventive therapy in the era of HIV infection: overview and research priorities. J Infect Dis 2007; 196(Suppl 1): S52-62 (in this supplement).
13. Marais BJ, Graham SM, Cotton MF, Beyers N. Diagnostic and management challenges for childhood tuberculosis in the era of HIV. J Infect Dis 2007; 196(Suppl 1):S76-85 (in this supplement).
14. Bock NN, Jensen PA, Miller B, Nardell E. Tuberculosis infection control in resource-limited settings in the era of expanding HIV care and treatment. J Infect Dis 2007; 196(Suppl 1):S108-13 (in this supplement).
15. Wells CD, Cegielski JP, Nelson LJ, et al. HIV infection and multidrug-resistant tuberculosis - the perfect storm. J Infect Dis 2007; 196(Suppl 1):S86-107 (in this supplement).
16. Friedland G, Harries A, Coetzee D. Implementation issues in tuberculosis/HIV program collaboration and integration: 3 case studies. J Infect Dis 2007; 196(Suppl 1):S114-23 (in this supplement).
17. Bartlett JG. Tuberculosis and HIV infection: partners in human tragedy. J Infect Dis 2007; 196(Suppl 1):S124-5 (in this supplement).